Streetbeat News

Stock Prices

IRON

Disc Medicine (NASDAQ:IRON) has received positive analyst ratings in the last quarter, with 6 bullish and 4 somewhat bullish ratings. Over the past 3 months, 10 analysts have offered 12-month price targets for Disc Medicine, with an average price target of $63.2, an increase of 32.0% from the previous average price target of $47.88.

Portfolio Pulse from Benzinga Insights

August 14, 2023 | 2:00 pm

MRNA

Moderna (NASDAQ:MRNA) has outperformed the market over the past 5 years, producing an average annual return of 39.6%. An investment of $1000 in MRNA stock 5 years ago would be worth $5,302.15 today. The company currently has a market capitalization of $37.50 billion.

Portfolio Pulse from Benzinga Insights

August 14, 2023 | 2:00 pm

CPRT

Over the past 20 years, Copart (NASDAQ:CPRT) has outperformed the market by 16.34% on an annualized basis, producing an average annual return of 24.05%. If an investor had bought $1000 of CPRT stock 20 years ago, it would be worth $77,767.44 today.

Portfolio Pulse from Benzinga Insights

August 14, 2023 | 2:00 pm

BXSL

Blackstone Secured (NYSE:BXSL) has received 4 analyst ratings in the last quarter, with 1 being bullish and 3 somewhat bullish. The average price target is $29.62, indicating an upside from the current price of $27.22. The average price target has increased by 6.74% over the past month.

Portfolio Pulse from Benzinga Insights

August 14, 2023 | 2:00 pm

UPST

12 analysts have given their ratings on Upstart Hldgs (NASDAQ:UPST) over the last quarter, with 2 bullish, 3 indifferent, and 7 bearish. The average price target is $26.08, which is lower than the current price of $32.575, implying a downside. The average price target has increased by 43.53% over the past month.

Portfolio Pulse from Benzinga Insights

August 14, 2023 | 2:00 pm

TGTX

TG Therapeutics' CEO and President, Michael Weiss, has purchased 100,000 shares of the company at an average price of $10.13 per share, according to a Form4 filing with the SEC.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2023 | 2:00 pm

ERJ

Embraer SA (NYSE:ERJ) reported Q2 FY23 revenue of $1.292 billion, a 27% Y/Y increase, beating the consensus of $1.162 billion. The company delivered 47 jets in Q2, a 47% Y/Y increase, and reaffirmed its FY23 outlook. However, ERJ shares are trading lower by 4.55% at $14.28.

Portfolio Pulse from Lekha Gupta

August 14, 2023 | 1:59 pm

HRYU

Shares of Hanryu Holdings were halted on a circuit breaker to the upside, with the stock now up by 37.9%.

Portfolio Pulse from Happy Mohamed

August 14, 2023 | 1:59 pm

BTAI

MNDY

ZYNE

U.S. stocks traded mostly lower with the Dow Jones falling around 50 points. Monday.com Ltd reported better-than-expected earnings for its second quarter and raised its 2023 revenue guidance. Zynerba Pharmaceuticals, Taysha Gene Therapies, and TMC the metals company saw their shares rise significantly. BioXcel Therapeutics, Hawaiian Electric Industries, and AMC Entertainment Holdings saw their shares drop significantly.

Portfolio Pulse from Lisa Levin

August 14, 2023 | 1:57 pm

TSHA

Shares of Taysha Gene Therapies have resumed trading.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2023 | 1:53 pm